+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Migraine Drug"

From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • February 2025
  • 193 Pages
  • Global
From
Migraine Drugs Market Report 2025 - Product Thumbnail Image

Migraine Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Migraine - Pipeline Insight, 2024 - Product Thumbnail Image

Migraine - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Migraine Drugs Market in Latin America 2024-2028 - Product Thumbnail Image

Migraine Drugs Market in Latin America 2024-2028

  • Report
  • September 2024
  • 163 Pages
  • Latin America
From
Migraine Market Report 2025 - Product Thumbnail Image

Migraine Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Migraine: Epidemiology Forecast to 2033 - Product Thumbnail Image

Migraine: Epidemiology Forecast to 2033

  • Report
  • July 2024
  • 48 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • March 2025
  • 898 Pages
  • Global
From
Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • March 2025
  • 578 Pages
  • Global
From
Headache Disorders Market Report 2025 - Product Thumbnail Image

Headache Disorders Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pain Management Devices Market 2024-2028 - Product Thumbnail Image

Pain Management Devices Market 2024-2028

  • Report
  • July 2024
  • 172 Pages
  • Global
From
From
Migraine: 68-Market Analysis and Sales Forecast - Product Thumbnail Image

Migraine: 68-Market Analysis and Sales Forecast

  • Report
  • August 2024
  • 18 Pages
  • Global
From
Loading Indicator

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists. Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more